{
  "actions": [
    {
      "acted_at": "2021-09-30",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2021-09-30",
      "action_code": "B00100",
      "references": [
        {
          "reference": "CR E1050",
          "type": null
        }
      ],
      "text": "Sponsor introductory remarks on measure.",
      "type": "action"
    },
    {
      "acted_at": "2021-09-30",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2021-10-01",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr5435-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "B001298",
      "district": "2",
      "name": "Bacon, Don",
      "original_cosponsor": true,
      "sponsored_at": "2021-09-30",
      "state": "NE",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001080",
      "district": "27",
      "name": "Chu, Judy",
      "original_cosponsor": false,
      "sponsored_at": "2022-01-20",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "F000466",
      "district": "1",
      "name": "Fitzpatrick, Brian K.",
      "original_cosponsor": false,
      "sponsored_at": "2021-12-09",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000381",
      "district": "6",
      "name": "Kilmer, Derek",
      "original_cosponsor": false,
      "sponsored_at": "2022-01-20",
      "state": "WA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000096",
      "district": "9",
      "name": "Pascrell, Bill, Jr.",
      "original_cosponsor": true,
      "sponsored_at": "2021-09-30",
      "state": "NJ",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "T000469",
      "district": "20",
      "name": "Tonko, Paul",
      "original_cosponsor": false,
      "sponsored_at": "2022-02-02",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-09-30",
  "number": "5435",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a Neuroscience Translation Working Group, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "BRAIN Act of 2021",
  "sponsor": {
    "bioguide_id": "B000574",
    "district": "3",
    "name": "Blumenauer, Earl",
    "state": "OR",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-09-30",
  "subjects": [
    "Advisory bodies",
    "Department of Health and Human Services",
    "Drug therapy",
    "Executive agency funding and structure",
    "Food and Drug Administration (FDA)",
    "Health",
    "Medical research",
    "Neurological disorders",
    "Scientific communication"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2021-09-30",
    "date": "2022-04-15T18:30:39Z",
    "text": "Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021\n\nThis bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.\n\nThe center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.\n\nThe FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a Neuroscience Translation Working Group, and for other purposes.",
      "type": "official"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "BRAIN Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "BRAIN Act of 2021",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Bringing Regulatory Advances Into Neuroscience Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-03-09T17:47:08Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr5435.xml"
}